Article

A Randomized, Controlled Study on the Safety and Efficacy of Maraviroc and/or Favipiravir Vs Currently Used Therapy in Severe COVID-19 Adults. (COMVIVIR, clinicaltrials.gov NCT04475991)

2021-01-05

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Multiple studies have now established that hyperinflammatory response induced by SARS CoV-2 is a main cause of complications and death in infected subjects. Such dysfunctional immune response has been described as a dysregulated and exacerbated production of cytokines and chemokines that attracts and activates inflammatory cells, which start and sustain pulmonar...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6a34aa13-7fea-5859-9c23-a08c3f76f03d
DOI: 10.21203/rs.3.rs-136884/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Randomized, Controlled Study on the Safety and Efficacy of Maraviroc and/or Favipiravir Vs Currently Used Therapy in Severe COVID-19 Adults. (COMVIVIR, clinicaltrials.gov NCT04475991)DOI 10.21203/rs.3.rs-136884/v1Read

A Randomized, Controlled Study on the Safety and Efficacy of Maraviroc and/or Favipiravir vs Currently Used Therapy in Severe COVID-19 Adults. “COMVIVIR” Trial.Semantic proximity Read

Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic InterventionsSemantic proximity Read

Tocilizumab treatment leads to early resolution of lymphopenia and myeloid dysregulation in patients hospitalized with COVID-19Semantic proximity Read

COVID-19–Associated Macrophage Activation Syndrome: Clinical Characteristics, Treatment Patterns, and Outcomes from a Hospitalized CohortSemantic proximity Read

Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.Semantic proximity Read

miR-146a, miR-221, and miR-155 are Involved in Inflammatory Immune Response in Severe COVID-19 PatientsSemantic proximity Read

COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve out- come in severe casesSemantic proximity Read

Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in severe COVID-19Semantic proximity Read

On whether therapeutic plasma exchange is an effective cure against severe/critical COVID-19 pneumoniaSemantic proximity Read

On Whether Therapeutic Plasma Exchange is Effective Against Severe/Critical COVID-19 PneumoniaSemantic proximity Read

Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patientsSemantic proximity Read

Transcriptomic Analysis of the Peripheral Immune Cell of SARS-CoV-2 Infected Patients for Bridging the Genotype-Phenotype Gap and Drug Prediction: A Precision Medicine ApproachSemantic proximity Read